Citation Impact

Citing Papers

Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
2017 Standout
Melatonin attenuates D‐galactose‐induced memory impairment, neuroinflammation and neurodegeneration via RAGE/NFKB/JNK signaling pathway in aging mouse model
2014 Standout
Lecanemab, Aducanumab, and Gantenerumab — Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease
2022
Randomized phase I clinical trial of anti–α‐synuclein antibody BIIB054
2019
Development of P assive I mmunotherapies for S ynucleinopathies
2015
Genetic Dissection of the Amyloid Precursor Protein in Developmental Function and Amyloid Pathogenesis
2010 StandoutNobel
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
2021
Alzheimer's disease: synaptic dysfunction and Aβ
2009
Genetic Animal Models of Cerebral Vasculopathies
2011
Amyloid‐ß‐directed immunotherapy for Alzheimer's disease
2014
Synapses and Alzheimer's Disease
2012 StandoutNobel
Parkinson disease
2017 Standout
Reconstitution of an in vitro poly(ADP-ribose) turnover system
1990
The Amyloid-β Pathway in Alzheimer’s Disease
2021
Mammalian single-strand break repair: Mechanisms and links with chromatin
2006
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
2011 Standout
Parkinson's disease
2021 Standout
Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate
2016
Current state and future directions of neurochemical biomarkers for Alzheimer's disease
2007
Intraneuronal amyloid β and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease
2006
Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Aβ assembly forms throughout life
2009
Aβ Oligomers – a decade of discovery
2007 Standout
Pathological roles of MAPK signaling pathways in human diseases
2010 Standout
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
2019 Standout
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
2015 Standout
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Intraneuronal Aβ detection in 5xFAD mice by a new Aβ-specific antibody
2012
Mitochondrial Dysfunction and Neurodegeneration in Lysosomal Storage Disorders
2017
Comparative Exploratory Analysis of Intrinsically Disordered Protein Dynamics Using Machine Learning and Network Analytic Methods
2019
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
2017 Standout
Dual Function for Poly(ADP-ribose) Synthesis in Response to DNA Strand Breakage
1994 StandoutNobel
The presence of sodium dodecyl sulphate-stable Aβ dimers is strongly associated with Alzheimer-type dementia
2010
The oligopeptide transport system of Bacillus subtilis plays a role in the initiation of sporulation
1991
Amyloid β-Protein Dimers Rapidly Form Stable Synaptotoxic Protofibrils
2010
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
2002 Standout
Parkin mediates beclin-dependent autophagic clearance of defective mitochondria and ubiquitinated A  in AD models
2011
Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
2015 Standout
Characterisation of two antibodies to oligomeric Aβ and their use in ELISAs on human brain tissue homogenates
2008
Tau in physiology and pathology
2015 Standout
Amyloid-β Protein Oligomer at Low Nanomolar Concentrations Activates Microglia and Induces Microglial Neurotoxicity
2010
Measurement of Aβ1–42 in cerebrospinal fluid is influenced by matrix effects
2011
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations
2010 Standout
Inhibition of Amyloid Formation
2012
Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
2018
Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody
2016
A highly insoluble state of Aβ similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice
2008
Large Aggregates Are the Major Soluble Aβ Species in AD Brain Fractionated with Density Gradient Ultracentrifugation
2012
Cell cycle regulation of poly(ADP-ribose) synthetase in FR3T3 cells
1988
Prion-like aggregates: infectious agents in human disease
2010
Synthesis of a library of oligothiophenes and their utilization as fluorescent ligands for spectral assignment of protein aggregates
2011
Neuropathological Alterations in Alzheimer Disease
2011 Standout
Alzheimer's disease
2016 Standout
Comparison of Aβ levels in the brain of familial and sporadic Alzheimer's disease
2009
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
Mechanism of Cerebral β-Amyloid Angiopathy: Murine and Cellular Models
2006
Sensitive ELISA detection of amyloid‐β protofibrils in biological samples
2007
Alzheimer's Disease
2010 Standout
Intracellular Aβ and cognitive deficits precede β-amyloid deposition in transgenic arcAβ mice
2006
Non-motor features of Parkinson disease
2017 Standout
The Amyloid State of Proteins in Human Diseases
2012 Standout
Processing of Mutant β-Amyloid Precursor Protein and the Clinicopathological Features of Familial Alzheimer’s Disease
2018
Mutant A53T α-Synuclein Induces Neuronal Death by Increasing Mitochondrial Autophagy
2011
Learning Decreases Aβ*56 and Tau Pathology and Ameliorates Behavioral Decline in 3xTg-AD Mice
2007
Rearrangements of the nucleosome structure in chromatin by poly(ADP-ribose)
1992
The Pathobiology of Vascular Dementia
2013 Standout
Poly(ADP-ribosyl)ation of chromatin in an in-vitro poly(ADP-ribose)-turnover system
1992
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
2012 Standout
Intracellular amyloid-β in Alzheimer's disease
2007 Standout
The amyloid state and its association with protein misfolding diseases
2014 Standout
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors
2015
Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP
2010 StandoutNobel
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Specific Uptake of an Amyloid-β Protofibril-Binding Antibody-Tracer in AβPP Transgenic Mouse Brain
2013
Coordination of redox active metal ions to the amyloid precursor protein and to amyloid-β peptides involved in Alzheimer disease. Part 2: Dependence of Cu(II) binding sites with Aβ sequences
2012
Alzheimer's disease
2017 Standout
Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling
2011 Standout
Loss of Astrocyte Polarization in the Tg-ArcSwe Mouse Model of Alzheimer's Disease
2011
Lecanemab in Early Alzheimer’s Disease
2022 Standout
The neuropathological diagnosis of Alzheimer’s disease
2019 Standout
Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation
2015
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
2012 Standout
Lysosomal activity regulatesCaenorhabditis elegansmitochondrial dynamics through vitamin B12 metabolism
2020 StandoutNobel
Amyloid β peptide cleavage by kallikrein 7 attenuates fibril growth and rescues neurons from Aβ-mediated toxicity in vitro
2013 StandoutNobel
New ELISAs with high specificity for soluble oligomers of amyloid β‐protein detect natural Aβ oligomers in human brain but not CSF
2013
Impairment of paravascular clearance pathways in the aging brain
2014 Standout
Basic science breaks through: New therapeutic advances in Parkinson's disease
2015
Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
1999 Standout
Serial propagation of distinct strains of Aβ prions from Alzheimer’s disease patients
2014 Nobel
Differential regulation of S-region hypermutation and class-switch recombination by noncanonical functions of uracil DNA glycosylase
2014 StandoutNobel
Water-Soluble Conjugated Polymers for Imaging, Diagnosis, and Therapy
2012 Standout
Sequential ADP‐ribosylation pattern of nucleosomal histones
1985
Adenosine Diphosphate Ribosylation of Chicken‐Erythrocyte Histones H1, H5 and High‐Mobility‐Group Proteins by Purified Calf‐Thymus Poly(adenosinediphosphate‐ribose) Polymerase
1982
A Chiral Macrocyclic Oligothiophene with Broken Conjugation – Rapid Racemization through Internal Rotation
2018 StandoutNobel
Disentangling Rotational Dynamics and Ordering Transitions in a System of Self-Organizing Protein Nanorods via Rotationally Invariant Latent Representations
2021 StandoutNobel
ABC Transporters: From Microorganisms to Man
1992 Standout
Imaging Distinct Conformational States of Amyloid-β Fibrils in Alzheimer’s Disease Using Novel Luminescent Probes
2007
The Development of Amyloid β Protein Deposits in the Aged Brain
2006
Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases
2016

Works of Anna Lord being referenced

Sensitive detection of Aβ protofibrils by proximity ligation - relevance for Alzheimer's disease
2010
Amyloid‐β protofibril levels correlate with spatial learning in Arctic Alzheimer’s disease transgenic mice
2009
Observations in APP Bitransgenic Mice Suggest that Diffuse and Compact Plaques Form via Independent Processes in Alzheimer's Disease
2011
The Arctic amyloid-β precursor protein (AβPP) mutation results in distinct plaques and accumulation of N- and C-truncated Aβ
2011
Amyloid‐β oligomers are inefficiently measured by enzyme‐linked immunosorbent assay
2005
Animal models of amyloid‐β‐related pathologies in Alzheimer’s disease
2010
The Arctic Alzheimer mutation favors intracellular amyloid‐β production by making amyloid precursor protein less available to α‐secretase
2007
Immunotherapy targeting α-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] α-synuclein mice
2014
An amyloid-β protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease
2009
Heavy-Chain Complementarity-Determining Regions Determine Conformation Selectivity of Anti-Aβ Antibodies
2010
The Arctic Alzheimer mutation facilitates early intraneuronal Aβ aggregation and senile plaque formation in transgenic mice
2005
Properties of poly(ADP-ribose) synthetase from rat pancreas and poly(ADP-ribosylation) of basic nuclear proteins
1978
Monoclonal antibodies selective for α‐synuclein oligomers/protofibrils recognize brain pathology in Lewy body disorders and α‐synuclein transgenic mice with the disease‐causing A30P mutation
2013
The Murine Version of BAN2401 (mAb158) Selectively Reduces Amyloid-β Protofibrils in Brain and Cerebrospinal Fluid of tg-ArcSwe Mice
2014
Phosphonopeptides as substrates for peptide transport systems and peptidases of Escherichia coli
1983
Rankless by CCL
2026